Söreskog E1, Borgström F1,2, Shepstone L3, Clarke S4, Cooper C5,6,7, Harvey I3, Harvey NC5,6, Howe A3, Johansson H8,9,10, Marshall T11, O’Neill TW12,13, Peters TJ14, Redmond NM14,15, Turner D3, Holland R16, McCloskey E8,17,18, Kanis JA19,20; SCOOP study team.
Osteoporos Int. 2020 Apr 1. doi: 10.1007/s00198-020-05372-6. [Epub ahead of print]
Community-based screening and treatment of women aged 70-85 years at high fracture risk reduced fractures; moreover, the screening programme was cost-saving. The results support a case for a screening programme of fracture risk in older women in the UK.
The SCOOP (screening for prevention of fractures in older women) randomized controlled trial investigated whether community-based screening could reduce fractures in women aged 70-85 years. The objective of this study was to estimate the long-term cost-effectiveness of screening for fracture risk in a UK primary care setting compared with usual management, based on the SCOOP study.
A health economic Markov model was used to predict the life-time consequences in terms of costs and quality of life of the screening programme compared with the control arm. The model was populated with costs related to drugs, administration and screening intervention derived from the SCOOP study. Fracture risk reduction in the screening arm compared with the usual management arm was derived from SCOOP. Modelled fracture risk corresponded to the risk observed in SCOOP.
Screening of 1000 patients saved 9 hip fractures and 20 non-hip fractures over the remaining lifetime (mean 14 years) compared with usual management. In total, the screening arm saved costs (£286) and gained 0.015 QALYs/patient in comparison with usual management arm.
This analysis suggests that a screening programme of fracture risk in older women in the UK would gain quality of life and life years, and reduce fracture costs to more than offset the cost of running the programme.